Martine Mouly

Calixar SAS provides services for the production, extraction, and purification of functional membrane proteins. It offers protein sequence analysis and design optimization, protein expression/production, extraction/solubilization/purification/stabilization, structural and functionality tests, scale-up, crystallography tests, and 3D structure determination services. The firm provides its services for drug and target, vaccine, and antibody discovery applications. The company was founded by Emmanuel Dejean and Pierre Falson in January 2011 and is headquartered in Lyon, France.

Calixar SAS provides services for the production, extraction, and purification of functional membrane proteins. It offers protein sequence analysis and design optimization, protein expression/production, extraction/solubilization/purification/stabilization, structural and functionality tests, scale-up, crystallography tests, and 3D structure determination services. The firm provides its services for drug and target, vaccine, and antibody discovery applications. The company was founded by Emmanuel Dejean and Pierre Falson in January 2011 and is headquartered in Lyon, France.

Calixar SAS provides services for the production, extraction, and purification of functional membrane proteins. It offers protein sequence analysis and design optimization, protein expression/production, extraction/solubilization/purification/stabilization, structural and functionality tests, scale-up, crystallography tests, and 3D structure determination services. The firm provides its services for drug and target, vaccine, and antibody discovery applications. The company was founded by Emmanuel Dejean and Pierre Falson in January 2011 and is headquartered in Lyon, France.